These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20936439)

  • 1. Analysis of bead sizes for MR capsules labeled for sprinkle.
    Nagavelli LR; Lionberger RA; Sayeed VA; Yu L; Allgire J; Smith A; Wokovich A; Westenberger BJ; Buhse L
    AAPS PharmSciTech; 2010 Dec; 11(4):1508-10. PubMed ID: 20936439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic omeprazole delayed-release capsules: in vitro performance evaluations.
    Moore T; Smith A; Ye W; Toler DY; Westenberger BJ; Lionberger R; Raw A; Yu L; Buhse LF
    Drug Dev Ind Pharm; 2009 Aug; 35(8):917-21. PubMed ID: 19555236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.
    Wang R; Conner DP; Li BV
    AAPS J; 2017 Mar; 19(2):360-366. PubMed ID: 28004346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling and simulation of biopharmaceutical performance.
    Zhang X; Lionberger RA
    Clin Pharmacol Ther; 2014 May; 95(5):480-2. PubMed ID: 24747237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA mulls changes to bioequivalence standards.
    Traynor K
    Am J Health Syst Pharm; 2010 Jun; 67(11):864. PubMed ID: 20484205
    [No Abstract]   [Full Text] [Related]  

  • 7. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-triggered release from multilayered capsules.
    De Geest BG; Skirtach AG; Mamedov AA; Antipov AA; Kotov NA; De Smedt SC; Sukhorukov GB
    Small; 2007 May; 3(5):804-8. PubMed ID: 17385759
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral controlled release preparations.
    García CR; Siqueiros A; Benet LZ
    Pharm Acta Helv; 1978; 53(3-4):99-109. PubMed ID: 360228
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of Clinical Pharmacology Principles in Drug Development of Modified-Release Products: Leveraging Exposure-Response Information to Support Approval.
    AbuAsal BS; Hamed SS; Ahmed MA; Al-Mansour L; Uppoor R; Mehta M
    J Clin Pharmacol; 2020 Nov; 60(11):1441-1452. PubMed ID: 32453882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
    Ostroff C; Lee CE; McMeekin J
    Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Level A Type IVIVC for the Rational Design of Clinical Trials Toward Regulatory Approval of Generic Polymeric Long-Acting Injectables.
    Somayaji MR; Das D; Przekwas A
    Clin Pharmacokinet; 2016 Oct; 55(10):1179-1190. PubMed ID: 27349905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for additional metrics to assess therapeutic equivalence of some multiphasic modified-release products.
    Kondra PM; Endrenyi L; Tothfalusi L
    Clin Ther; 2011 Sep; 33(9):1214-9. PubMed ID: 21849209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic drug product equivalence: current status.
    Meyer MC
    Am J Manag Care; 1998 Aug; 4(8):1183-9; quiz 1190-2. PubMed ID: 10182892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence of verapamil hydrochloride extended-release pellet-filled capsules when opened and sprinkled on food and when swallowed intact.
    Kozloski GD; De Vito JM; Johnson JB; Holmes GB; Adams MA; Hunt TL
    Clin Pharm; 1992 Jun; 11(6):539-42. PubMed ID: 1600686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes.
    Clark AM; Pellock JM; Holmay M; Anders B; Cloyd J
    Epilepsy Behav; 2016 Apr; 57(Pt A):105-110. PubMed ID: 26943947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific Considerations for the Review and Approval of First Generic Mometasone Furoate Nasal Suspension Spray in the United States from the Bioequivalence Perspective.
    Liu Q; Absar M; Saluja B; Guo C; Chowdhury B; Lionberger R; Conner DP; Li BV
    AAPS J; 2019 Jan; 21(2):14. PubMed ID: 30617594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FDA's generic-drug approval process: similarities to and differences from brand-name drugs.
    Kefalas CH; Ciociola AA
    Am J Gastroenterol; 2011 Jun; 106(6):1018-21. PubMed ID: 21637264
    [No Abstract]   [Full Text] [Related]  

  • 20. Sprinkle formulations-A review of commercially available products.
    Lee HS; Lee JJ; Kim MG; Kim KT; Cho CW; Kim DD; Lee JY
    Asian J Pharm Sci; 2020 May; 15(3):292-310. PubMed ID: 32636948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.